TNFα inhibitor induced lupus-like syndrome (TAILS) in a patient with IBD.

about

TNFα inhibitor induced lupus-like syndrome (TAILS) in a patient with IBD.

Item

http://www.wikidata.org/entity/Q36453770

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

TNFα inhibitor induced lupus-like syndrome (TAILS) in a patient with IBD.

@ast

TNFα inhibitor induced lupus-like syndrome (TAILS) in a patient with IBD.

@en

type

Item

label

TNFα inhibitor induced lupus-like syndrome (TAILS) in a patient with IBD.

@ast

TNFα inhibitor induced lupus-like syndrome (TAILS) in a patient with IBD.

@en

prefLabel

TNFα inhibitor induced lupus-like syndrome (TAILS) in a patient with IBD.

@ast

TNFα inhibitor induced lupus-like syndrome (TAILS) in a patient with IBD.

@en

P1476

TNFα inhibitor induced lupus-like syndrome (TAILS) in a patient with IBD.

@en

P2093

A Lupu

http://www.w3.org/2001/XMLSchema#string

C L Constantinescu

http://www.w3.org/2001/XMLSchema#string

C Tieranu

http://www.w3.org/2001/XMLSchema#string

M Diculescu

http://www.w3.org/2001/XMLSchema#string

P2860

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

Mechanisms of tumor necrosis factor α antagonist-induced lupus in a murine model.

Unusual toxicities with TNF inhibition: heart failure and drug-induced lupus.

Psoriasis, psoriatic arthritis and increased risk of incident Crohn's disease in US women.

Drug-induced lupus due to anti-tumor necrosis factor alpha agents.

Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic

Enteropathic spondyloarthropathy: a common genetic background with inflammatory bowel disease?

Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review.

P304

285-288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12865/CHSJ.40.04.11

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26788358

http://www.w3.org/2001/XMLSchema#string

P932

4709703

http://www.w3.org/2001/XMLSchema#string